Lolita Petit
Company: Coave Therapeutics
Job title: Chief Scientific Officer
Seminars:
Chair’s Opening Remarks 8:55 am
day: Conference Day Two
Leveraging Transgenic Animal Models for Robust In Vivo Validation of Therapeutic Targets in Inherited Retinal Diseases 4:00 pm
Choosing disease-specific knockout mouse models to accurately mirror human genetic pathology and provide relevant efficacy data Collaborating with pre-clinical partners experienced in retinal gene delivery to optimize vector administration protocols Collecting longitudinal functional and histological evidence of therapeutic benefit to build compelling proof-of-concept data supporting regulatory confidenceRead more
day: Conference Day One